HLA-DRB1

RNA & survival
SurvivalRNAKaplan–Meier · TCGA cohorts

Across TCGA pan-cancer cohorts, HLA-DRB1 RNA is linked to patient survival in 25 of 34 cancer types, making it the most broadly survival-associated HLA-DRB1 data layer compared with 2 for mutation status and 7 for mass-spec protein.

The strongest signal is observed in skin cutaneous melanoma (SKCM), where higher HLA-DRB1 RNA is associated with better overall survival. In most high-consensus cancer types, elevated HLA-DRB1 expression acts as an unfavorable survival marker, although some lineages such as SKCM and KIRC show a favorable association.

SKCM, UVM, and LGG are the cancer types where HLA-DRB1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.
LineageMeasureSplitStageAUC1
high
AUC2
low
pSampling consensus
SKCMOSMedianAll0.4430.255<.001127view →
UVMDFSMedianAll0.3850.828<.00171view →
LGGOSMedianAll0.7440.871<.00151view →
KIRCDFSMedianII,III,IV0.6190.361.00850view →
THYMDFSQuartileAll0.4720.915.00228view →
LUADDFSMedianAll0.8340.747.00526view →
LIHCDFSQuartileII,III,IV0.5600.308.00124view →
HNSCDFSQuartileIII,IV0.6380.463.01723view →
CESCOSQuartileIII,IV0.8530.499.01818view →
ACCDFSMedianAll0.6740.333.01516view →
LAMLDFSQuartileAll0.3020.660.00216view →
KIRPDFSQuartileAll0.4080.811.01514view →
Pink = unfavorable, green = favorable. Showing the 12 strongest of 25 lineages.

Exploration